Umbilical cord blood transplantation: Still growing and improving.
Zhu X, Tang B, Sun Z.
Stem Cells Transl Med. 2021 Nov;10 Suppl 2(Suppl 2):S62-S74. doi: 10.1002/sctm.20-0495.
Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: current challenges and strategies.
Malhotra M, Shenoy S.
Transfus Apher Sci. 2022 Oct;61(5):103554. doi: 10.1016/j.transci.2022.103554. Epub 2022 Aug 29.
Immunotherapy after hematopoietic stem cell transplantation using umbilical cord blood-derived products.
Saudemont A, Madrigal JA.
Cancer Immunol Immunother. 2017 Feb;66(2):215-221. doi: 10.1007/s00262-016-1852-3. Epub 2016 Jun 6.
Umbilical cord blood banking in the worldwide hematopoietic stem cell transplantation system: perspectives for Ukraine.
Kalynychenko TO.
Exp Oncol. 2017 Sep;39(3):164-170.
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
Horwitz ME, Stiff PJ, Cutler C, Brunstein C, Hanna R, Maziarz RT, Rezvani AR, Karris NA, McGuirk J, Valcarcel D, Schiller GJ, Lindemans CA, Hwang WYK, Koh LP, Keating A, Khaled Y, Hamerschlak N, Frankfurt O, Peled T, Segalovich I, Blackwell B, Wease S, Freedman LS, Galamidi-Cohen E, Sanz G.
Blood. 2021 Oct 21;138(16):1429-1440. doi: 10.1182/blood.2021011719.
Hematopoietic Stem and Progenitor Cells (HSPCs).
Bujko K, Kucia M, Ratajczak J, Ratajczak MZ.
Adv Exp Med Biol. 2019;1201:49-77. doi: 10.1007/978-3-030-31206-0_3.
Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.
Shi PA, Luchsinger LL, Greally JM, Delaney CS.
Curr Opin Hematol. 2022 Nov 1;29(6):317-326. doi: 10.1097/MOH.0000000000000732. Epub 2022 Aug 29.
Results of unrelated umbilical cord blood hematopoietic stem cell transplantation.
Gluckman E, Rocha V, Chevret S.
Rev Clin Exp Hematol. 2001 Jun;5(2):87-99. doi: 10.1046/j.1468-0734.2001.00034.x.
Current status of umbilical cord blood hematopoietic stem cell transplantation.
Gluckman E.
Exp Hematol. 2000 Nov;28(11):1197-205. doi: 10.1016/s0301-472x(00)00540-3.
Therapeutic Perspectives for the Clinical Application of Umbilical Cord Hematopoietic and Mesenchymal Stem Cells: Overcoming Complications Arising After Allogeneic Hematopoietic Stem Cell Transplantation.
Gudauskaitė G, Kairienė I, Ivaškienė T, Rascon J, Mobasheri A.
Adv Exp Med Biol. 2023;1409:111-126. doi: 10.1007/5584_2022_726.
